Literature DB >> 17235693

Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder.

Lusha Liu1, S Charles Schulz, Susanne Lee, Teri J Reutiman, S Hossein Fatemi.   

Abstract

1. Schizophrenia and bipolar disorder are neurodevelopmental disorders with significant genetic vulnerabilities. Several trophic genes and/or proteins have been implicated in the causation for both disorders.2. We hypothesized that these genes and/or proteins may impact neuronal growth in both disorders.3. Hippocampal tissue sections from CA1 area of schizophrenic, bipolar, depressed, and controls subjects, matched for age, sex, PMI, drug exposure, and brain pH were prepared for cell size determination using the Stanley Medical Research Foundation postmortem brain collection.4. Quantification of hippocampal CA1 pyramidal neuron size showed a significant 12% reduction in cell size (p < 0.05) in bipolar subjects vs. controls. There were nonsignificant trends for reduction in cell size in both schizophrenic and depressed subjects vs. controls.5. These results indicate for the first time that pyramidal cell atrophy is present in hippocampus of subjects with bipolar disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17235693     DOI: 10.1007/s10571-006-9128-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  20 in total

Review 1.  Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly.

Authors:  S H Fatemi
Journal:  Mol Psychiatry       Date:  2001-03       Impact factor: 15.992

2.  Genetics. Two genes link two distinct psychoses.

Authors:  Akira Sawa; Solomon H Snyder
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

3.  Developmental expression of Bcl-2 protein in human cortex.

Authors:  L F Jarskog; J H Gilmore
Journal:  Brain Res Dev Brain Res       Date:  2000-02-07

Review 4.  Reelin glycoprotein: structure, biology and roles in health and disease.

Authors:  S H Fatemi
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

5.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.

Authors:  A Guidotti; J Auta; J M Davis; V Di-Giorgi-Gerevini; Y Dwivedi; D R Grayson; F Impagnatiello; G Pandey; C Pesold; R Sharma; D Uzunov; E Costa; V DiGiorgi Gerevini
Journal:  Arch Gen Psychiatry       Date:  2000-11

6.  Bcl-2 promotes regeneration of severed axons in mammalian CNS.

Authors:  D F Chen; G E Schneider; J C Martinou; S Tonegawa
Journal:  Nature       Date:  1997-01-30       Impact factor: 49.962

7.  Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia.

Authors:  L F Jarskog; J H Gilmore; E S Selinger; J A Lieberman
Journal:  Biol Psychiatry       Date:  2000-10-01       Impact factor: 13.382

Review 8.  Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations.

Authors:  L Fredrik Jarskog
Journal:  Curr Opin Psychiatry       Date:  2006-05       Impact factor: 4.741

9.  Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects.

Authors:  Mohsen Araghi-Niknam; S Hossein Fatemi
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

10.  bcl-2 inhibits death of central neural cells induced by multiple agents.

Authors:  L T Zhong; T Sarafian; D J Kane; A C Charles; S P Mah; R H Edwards; D E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  20 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Henrik Dobrowolny; Dieter Krell; Renate Stauch; Kurt Trübner; Johann Steiner; Mounir N Ghabriel; Hendrik Bielau; Rainer Wolf; Jana Winter; Siegfried Kropf; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-07       Impact factor: 5.270

3.  Sex-dependent behavioral effects and morphological changes in the hippocampus after prenatal invasive interventions in rats: implications for animal models of schizophrenia.

Authors:  Martina von Wilmsdorff; Ulrich Sprick; Marie-Luise Bouvier; Daniela Schulz; Andrea Schmitt; Wolfgang Gaebel
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

4.  Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.

Authors:  Bo Cao; Isabelle E Bauer; Ajaykumar N Sharma; Benson Mwangi; Thomas Frazier; Luca Lavagnino; Giovana B Zunta-Soares; Consuelo Walss-Bass; David C Glahn; Flavio Kapczinski; David A Nielsen; Jair C Soares
Journal:  J Affect Disord       Date:  2016-03-10       Impact factor: 4.839

5.  Hippocampal interneurons in bipolar disorder.

Authors:  Christine Konradi; Eric I Zimmerman; C Kevin Yang; Kathryn M Lohmann; Paul Gresch; Harry Pantazopoulos; Sabina Berretta; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2010-12-06

6.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

7.  The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.

Authors:  Jing Du; Thomas K Creson; Long-Jun Wu; Ming Ren; Neil A Gray; Cynthia Falke; Yanling Wei; Yun Wang; Rayah Blumenthal; Rodrigo Machado-Vieira; Peixiong Yuan; Guang Chen; Min Zhuo; Husseini K Manji
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

8.  FKBP5 and attention bias for threat: associations with hippocampal function and shape.

Authors:  Negar Fani; David Gutman; Erin B Tone; Lynn Almli; Kristina B Mercer; Jennifer Davis; Ebony Glover; Tanja Jovanovic; Bekh Bradley; Ivo D Dinov; Alen Zamanyan; Arthur W Toga; Elisabeth B Binder; Kerry J Ressler
Journal:  JAMA Psychiatry       Date:  2013-04       Impact factor: 21.596

9.  Intracerebral Administration of BDNF Protects Rat Brain Against Oxidative Stress Induced by Ouabain in an Animal Model of Mania.

Authors:  Samira S Valvassori; Camila O Arent; Amanda V Steckert; Roger B Varela; Luciano K Jornada; Paula T Tonin; Josiane Budni; Edemilson Mariot; Flávio Kapczinski; João Quevedo
Journal:  Mol Neurobiol       Date:  2014-08-28       Impact factor: 5.590

Review 10.  Inositol depletion, GSK3 inhibition and bipolar disorder.

Authors:  Wenxi Yu; Miriam L Greenberg
Journal:  Future Neurol       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.